ZIPRASIDONE MESYLATE

ZIPRASIDONE MESYLATE was reported 14193 times

ZIPRASIDONE MESYLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OCULOGYRATION 21 0.1579
1 ANOSOGNOSIA 96 0.1250
2 BLOOD PROLACTIN ABNORMAL 94 0.1089
3 PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION 10 0.0800
4 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 59 0.0751
5 SCHIZOPHRENIA, PARANOID TYPE 20 0.0556
6 INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS 16 0.0518
7 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 32 0.0463
8 SCHIZOAFFECTIVE DISORDER 79 0.0443
9 DISTURBANCE IN SOCIAL BEHAVIOUR 93 0.0394
10 DIABETIC COMA 110 0.0392
11 DIABETIC NEUROPATHY 162 0.0327
12 DIABETIC COMPLICATION 79 0.0310
13 DIABETES MELLITUS NON-INSULIN-DEPENDENT 42 0.0289
14 DIABETIC EYE DISEASE 13 0.0288
15 IMPAIRED FASTING GLUCOSE 8 0.0262
16 OBESITY 410 0.0257
17 MASKED FACIES 10 0.0246
18 DIABETIC GASTROPARESIS 9 0.0245
19 TYPE 2 DIABETES MELLITUS 826 0.0245
20 TYPE 1 DIABETES MELLITUS 137 0.0227
21 METABOLIC DISORDER 132 0.0227
22 TARDIVE DYSKINESIA 632 0.0224
23 DYSTHYMIC DISORDER 7 0.0211
24 METABOLIC SYNDROME 34 0.0207
25 DYSTONIA 396 0.0204
26 GLYCOSURIA 27 0.0200
27 BORDERLINE PERSONALITY DISORDER 14 0.0197
28 BIPOLAR DISORDER 211 0.0194
29 NEUROLEPTIC MALIGNANT SYNDROME 226 0.0190
30 HYPERLIPIDAEMIA 208 0.0174
31 PROTRUSION TONGUE 10 0.0172
32 AKATHISIA 233 0.0171
33 BIPOLAR I DISORDER 37 0.0168
34 LACTATION DISORDER 8 0.0164
35 DISINHIBITION 26 0.0161
36 BLOOD PROLACTIN INCREASED 76 0.0161
37 BANKRUPTCY 7 0.0156
38 HOMICIDAL IDEATION 63 0.0155
39 SCHIZOPHRENIA 184 0.0151
40 MANIA 247 0.0150
41 BLOOD TRIGLYCERIDES INCREASED 260 0.0147
42 BRAIN DAMAGE 7 0.0142
43 EYE ROLLING 10 0.0141
44 DIABETES MELLITUS INSULIN-DEPENDENT 7 0.0139
45 PRIAPISM 48 0.0139
46 DIABETIC NEPHROPATHY 30 0.0136
47 TACHYPHRENIA 46 0.0133
48 TORTICOLLIS 28 0.0132
49 DIABETES MELLITUS 960 0.0126
50 PERSONALITY CHANGE 112 0.0120
51 HOSTILITY 30 0.0118
52 SEDATION 309 0.0118
53 SEXUAL DYSFUNCTION 138 0.0118
54 DIABETES MELLITUS INADEQUATE CONTROL 208 0.0117
55 GRIMACING 9 0.0115
56 PERSONALITY DISORDER 30 0.0114
57 HALLUCINATION, AUDITORY 181 0.0114
58 TONGUE PARALYSIS 8 0.0112
59 PARANOIA 193 0.0112
60 GLUCOSE TOLERANCE IMPAIRED 64 0.0108
61 PSYCHOGENIC SEIZURE 10 0.0107
62 BRUXISM 57 0.0106
63 JOINT SPRAIN 11 0.0105
64 COGWHEEL RIGIDITY 11 0.0105
65 HYPOMANIA 38 0.0103
66 EXTRAPYRAMIDAL DISORDER 255 0.0103
67 OCULOGYRIC CRISIS 22 0.0102
68 OBSESSIVE-COMPULSIVE DISORDER 81 0.0101
69 DIABETIC RETINOPATHY 34 0.0100
70 DYSKINESIA 406 0.0100
71 FLAT AFFECT 22 0.0095
72 BLUNTED AFFECT 7 0.0095
73 TOBACCO USER 14 0.0094
74 PSYCHOTIC DISORDER 279 0.0094
75 PANCREATITIS CHRONIC 22 0.0093
76 BINGE EATING 10 0.0093
77 COMPULSIVE SHOPPING 19 0.0092
78 NEUROPSYCHIATRIC SYMPTOMS 8 0.0089
79 FACIAL PALSY 19 0.0088
80 AGORAPHOBIA 12 0.0088
81 TRISMUS 45 0.0087
82 DROOLING 60 0.0087
83 PHYSICAL ASSAULT 18 0.0086
84 PANCREATITIS RELAPSING 7 0.0086
85 BLOOD CHOLESTEROL INCREASED 397 0.0085
86 ELECTROCARDIOGRAM CHANGE 8 0.0084
87 SUICIDAL BEHAVIOUR 35 0.0084
88 POLYCYSTIC OVARIES 13 0.0084
89 INTENTIONAL MISUSE 16 0.0084
90 DYSPHORIA 42 0.0083
91 DYSLIPIDAEMIA 42 0.0083
92 GALACTORRHOEA 53 0.0082
93 GAMBLING DISORDER 22 0.0081
94 DELUSION 125 0.0080
95 AUTONOMIC NEUROPATHY 8 0.0079
96 PARKINSON'S DISEASE 20 0.0079
97 HAEMORRHAGIC DIATHESIS 28 0.0079
98 DEMENTIA ALZHEIMER'S TYPE 13 0.0078
99 OBSESSIVE THOUGHTS 14 0.0078
100 VIOLENCE-RELATED SYMPTOM 12 0.0077
101 THINKING ABNORMAL 144 0.0077
102 MUTISM 11 0.0076
103 ABNORMAL SLEEP-RELATED EVENT 10 0.0076
104 TIC 41 0.0075
105 PANIC DISORDER 29 0.0075
106 EXCESSIVE EYE BLINKING 11 0.0074
107 DIABETIC KETOACIDOSIS 176 0.0073
108 ILLUSION 12 0.0073
109 PARKINSONISM 69 0.0071
110 HYPERGLYCAEMIA 251 0.0069
111 POLYDIPSIA 27 0.0068
112 THERAPEUTIC PRODUCT EFFECT VARIABLE 26 0.0067
113 CATATONIA 35 0.0067
114 HYPERPHAGIA 26 0.0065
115 GASTRIC BYPASS 14 0.0064
116 ELECTROCARDIOGRAM T WAVE ABNORMAL 10 0.0064
117 PANIC REACTION 46 0.0064
118 COMPLEX PARTIAL SEIZURES 7 0.0063
119 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 7 0.0063
120 ARTHRITIS INFECTIVE 29 0.0062
121 INSULIN RESISTANCE 13 0.0062
122 LOGORRHOEA 22 0.0062
123 DIABETIC FOOT 19 0.0062
124 ENURESIS 25 0.0062
125 GRANULOCYTOPENIA 35 0.0061
126 SINUS ARRHYTHMIA 8 0.0061
127 CARBON DIOXIDE DECREASED 7 0.0061
128 HYPERPROLACTINAEMIA 39 0.0060
129 SUICIDE ATTEMPT 364 0.0060
130 POST-TRAUMATIC STRESS DISORDER 40 0.0060
131 TONGUE DISORDER 43 0.0059
132 LIBIDO INCREASED 12 0.0059
133 KETOACIDOSIS 44 0.0059
134 BREAST DISCHARGE 10 0.0057
135 INCREASED APPETITE 109 0.0057
136 PANCREATITIS 301 0.0057
137 TERMINAL INSOMNIA 10 0.0056
138 LOSS OF EMPLOYMENT 17 0.0056
139 APPETITE DISORDER 37 0.0056
140 FEELING OF DESPAIR 26 0.0056
141 BREAST ENLARGEMENT 18 0.0055
142 EUPHORIC MOOD 56 0.0055
143 SLEEP PARALYSIS 8 0.0054
144 SELF INJURIOUS BEHAVIOUR 16 0.0052
145 MAJOR DEPRESSION 38 0.0052
146 BLOOD CHOLESTEROL ABNORMAL 24 0.0052
147 RESTLESSNESS 190 0.0052
148 SOMNAMBULISM 34 0.0052
149 MUSCLE TWITCHING 119 0.0052
150 DEREALISATION 11 0.0051
151 IMPRISONMENT 9 0.0051
152 IMPULSIVE BEHAVIOUR 19 0.0051
153 FEAR OF DISEASE 9 0.0051
154 DRUG SCREEN FALSE POSITIVE 14 0.0051
155 GESTATIONAL DIABETES 24 0.0050
156 SELF-INJURIOUS IDEATION 21 0.0050
157 ACTIVITIES OF DAILY LIVING IMPAIRED 99 0.0050
158 ABNORMAL BEHAVIOUR 196 0.0049
159 CATAPLEXY 7 0.0049
160 ALCOHOL ABUSE 13 0.0049
161 MUSCLE CONTRACTIONS INVOLUNTARY 17 0.0048
162 AGITATION 355 0.0048
163 JUDGEMENT IMPAIRED 7 0.0048
164 AGGRESSION 241 0.0048
165 PERSECUTORY DELUSION 12 0.0048
166 ELECTROCARDIOGRAM QT PROLONGED 173 0.0048
167 ANXIETY DISORDER 16 0.0048
168 NECK INJURY 14 0.0048
169 NARCOLEPSY 9 0.0048
170 GENERALISED ANXIETY DISORDER 7 0.0048
171 SUICIDAL IDEATION 432 0.0047
172 VISUAL DISTURBANCE 27 0.0047
173 PITUITARY TUMOUR 7 0.0047
174 GYNAECOMASTIA 145 0.0047
175 MUSCLE RIGIDITY 56 0.0047
176 EYE MOVEMENT DISORDER 32 0.0047
177 HYPOAESTHESIA FACIAL 7 0.0047
178 SKIN WARM 27 0.0046
179 CONVULSION 264 0.0046
180 PSYCHIATRIC DECOMPENSATION 9 0.0046
181 MENTAL DISORDER 200 0.0046
182 STARING 11 0.0045
183 SOCIAL AVOIDANT BEHAVIOUR 26 0.0045
184 OVERWEIGHT 24 0.0045
185 APPARENT DEATH 16 0.0044
186 DRUG SCREEN POSITIVE 35 0.0044
187 PSYCHOMOTOR HYPERACTIVITY 73 0.0044
188 ANGER 147 0.0043
189 HOMICIDE 8 0.0043
190 WEIGHT INCREASED 966 0.0043
191 COSTOCHONDRITIS 7 0.0043
192 SLEEP APNOEA SYNDROME 82 0.0043
193 PITUITARY TUMOUR BENIGN 7 0.0043
194 PRESCRIBED OVERDOSE 82 0.0042
195 RESTLESS LEGS SYNDROME 77 0.0042
196 SNORING 16 0.0042
197 FEELING DRUNK 31 0.0042
198 PRE-EXISTING CONDITION IMPROVED 26 0.0042
199 BILIARY DYSKINESIA 7 0.0041
200 CHOREA 7 0.0041
201 STUPOR 13 0.0040
202 HALLUCINATIONS, MIXED 17 0.0040
203 FEAR OF DEATH 9 0.0040
204 PANIC ATTACK 145 0.0040
205 BREAST CYST 7 0.0040
206 PSYCHIATRIC SYMPTOM 29 0.0039
207 SWOLLEN TONGUE 122 0.0039
208 THERAPEUTIC AGENT TOXICITY 13 0.0039
209 IMPULSE-CONTROL DISORDER 8 0.0039
210 BLOOD CHLORIDE DECREASED 10 0.0039
211 TORSADE DE POINTES 30 0.0038
212 DIFFICULTY IN WALKING 13 0.0038
213 HALLUCINATION 282 0.0037
214 HALLUCINATION, VISUAL 79 0.0037
215 ENERGY INCREASED 22 0.0037
216 ORAL INTAKE REDUCED 9 0.0037
217 MUSCLE DISORDER 30 0.0037
218 HANGOVER 13 0.0037
219 GUN SHOT WOUND 7 0.0037
220 TREMOR 609 0.0037
221 TENSION 22 0.0036
222 SCREAMING 23 0.0036
223 FEAR 97 0.0036
224 FORMICATION 25 0.0036
225 GRAND MAL CONVULSION 33 0.0036
226 HYPERSOMNIA 101 0.0035
227 MUSCLE TIGHTNESS 57 0.0035
228 LIPIDS INCREASED 7 0.0035
229 HUNGER 48 0.0034
230 SELF-MEDICATION 14 0.0034
231 COMMUNICATION DISORDER 13 0.0034
232 WITHDRAWAL SYNDROME 141 0.0034
233 LONG QT SYNDROME 8 0.0033
234 WEIGHT ABNORMAL 8 0.0033
235 ANORGASMIA 9 0.0033
236 SUDDEN DEATH 35 0.0033
237 AFFECTIVE DISORDER 26 0.0033
238 REBOUND ACID HYPERSECRETION 10 0.0033
239 HIGH DENSITY LIPOPROTEIN DECREASED 11 0.0033
240 REFUSAL OF TREATMENT BY PATIENT 21 0.0032
241 HYPERCHOLESTEROLAEMIA 31 0.0032
242 GASTROINTESTINAL TUBE INSERTION 8 0.0032
243 SOMNOLENCE 643 0.0032
244 ABNORMAL DREAMS 88 0.0032
245 ELECTROCARDIOGRAM ABNORMAL 25 0.0032
246 BLEPHAROSPASM 20 0.0032
247 EXCORIATION 8 0.0032
248 EMOTIONAL DISORDER 97 0.0031
249 CHOLECYSTITIS CHRONIC 21 0.0031
250 MENTAL IMPAIRMENT 75 0.0031
251 POSTURE ABNORMAL 10 0.0031
252 OEDEMA MOUTH 10 0.0031
253 IRRITABILITY 184 0.0031
254 CRYING 110 0.0030
255 MOOD SWINGS 96 0.0030
256 ERECTILE DYSFUNCTION 77 0.0030
257 ALCOHOL USE 11 0.0030
258 TENDERNESS 31 0.0030
259 THROMBOPHLEBITIS SUPERFICIAL 9 0.0030
260 GALLBLADDER DISORDER 53 0.0030
261 NERVOUSNESS 154 0.0029
262 MOVEMENT DISORDER 94 0.0029
263 SEROTONIN SYNDROME 56 0.0029
264 DEPRESSION 661 0.0029
265 BRAIN INJURY 29 0.0029
266 SELF ESTEEM DECREASED 7 0.0029
267 TONGUE OEDEMA 11 0.0029
268 DYSARTHRIA 108 0.0029
269 IMPAIRED DRIVING ABILITY 32 0.0028
270 INTERVERTEBRAL DISC DISORDER 12 0.0028
271 MYDRIASIS 36 0.0028
272 MULTIPLE DRUG OVERDOSE INTENTIONAL 9 0.0028
273 FRUSTRATION 10 0.0028
274 DISSOCIATION 21 0.0027
275 DYSPHEMIA 12 0.0027
276 EAR PAIN 53 0.0027
277 FAECAL INCONTINENCE 13 0.0027
278 FOOD CRAVING 14 0.0027
279 LEUKAEMIA 25 0.0026
280 THYROID FUNCTION TEST ABNORMAL 11 0.0026
281 INITIAL INSOMNIA 27 0.0026
282 THIRST 47 0.0026
283 MULTIPLE DRUG OVERDOSE 13 0.0026
284 ALCOHOL POISONING 7 0.0026
285 MASTICATION DISORDER 8 0.0026
286 VIITH NERVE PARALYSIS 9 0.0026
287 LARYNGOSPASM 7 0.0026
288 BLOOD SODIUM INCREASED 7 0.0026
289 ANXIETY 734 0.0026
290 ECONOMIC PROBLEM 39 0.0026
291 INSOMNIA 685 0.0026
292 POLYURIA 21 0.0026
293 DISTURBANCE IN ATTENTION 138 0.0026
294 ONYCHOMYCOSIS 11 0.0025
295 SALIVARY HYPERSECRETION 25 0.0025
296 PANCREATITIS ACUTE 56 0.0025
297 CATHETERISATION CARDIAC 11 0.0025
298 CARDIAC FLUTTER 16 0.0025
299 RHINITIS ALLERGIC 11 0.0025
300 INCONTINENCE 26 0.0025
301 MOTOR DYSFUNCTION 25 0.0025
302 PHOTOPHOBIA 46 0.0024
303 DRUG ABUSER 15 0.0024
304 ABNORMAL WEIGHT GAIN 30 0.0024
305 SPEECH DISORDER 127 0.0024
306 DRUG TOXICITY 33 0.0024
307 OTITIS MEDIA 8 0.0024
308 BUNDLE BRANCH BLOCK RIGHT 11 0.0024
309 LUMBAR SPINAL STENOSIS 7 0.0024
310 EATING DISORDER 51 0.0024
311 HYPERTRIGLYCERIDAEMIA 14 0.0024
312 AFFECT LABILITY 23 0.0024
313 NEGATIVE THOUGHTS 7 0.0024
314 PERFORMANCE STATUS DECREASED 11 0.0024
315 AMMONIA INCREASED 12 0.0023
316 SUDDEN CARDIAC DEATH 8 0.0023
317 FEELING ABNORMAL 561 0.0023
318 ANOREXIA 30 0.0023
319 HEPATITIS C 28 0.0023
320 INCOHERENT 15 0.0023
321 BACK INJURY 25 0.0023
322 DISORIENTATION 91 0.0023
323 ROAD TRAFFIC ACCIDENT 95 0.0023
324 HYPERVENTILATION 13 0.0022
325 RESPIRATORY RATE DECREASED 7 0.0022
326 URINARY INCONTINENCE 66 0.0022
327 MULTIPLE INJURIES 14 0.0022
328 DYSPHAGIA 211 0.0022
329 DRUG EFFECT INCREASED 7 0.0022
330 PHARYNGEAL OEDEMA 34 0.0022
331 BEDRIDDEN 29 0.0022
332 IMPAIRED WORK ABILITY 47 0.0022
333 AMNESIA 143 0.0022
334 DRUG TOLERANCE 11 0.0022
335 HEARING IMPAIRED 13 0.0022
336 NEPHROGENIC ANAEMIA 10 0.0022
337 INTENTIONAL DRUG MISUSE 45 0.0022
338 COORDINATION ABNORMAL 30 0.0021
339 VAGINAL INFECTION 10 0.0021
340 ORTHOSTATIC HYPOTENSION 37 0.0021
341 NIGHTMARE 73 0.0021
342 TREATMENT NONCOMPLIANCE 114 0.0021
343 SENSATION OF HEAVINESS 8 0.0021
344 AMENORRHOEA 36 0.0021
345 MICTURITION DISORDER 7 0.0020
346 CAROTID ARTERY STENOSIS 7 0.0020
347 LOSS OF CONSCIOUSNESS 255 0.0020
348 APATHY 29 0.0020
349 HEPATIC STEATOSIS 37 0.0020
350 ABASIA 49 0.0020
351 GALLBLADDER OPERATION 8 0.0020
352 DYSGRAPHIA 13 0.0020
353 SINUS BRADYCARDIA 19 0.0020
354 MUSCLE STRAIN 17 0.0020
355 PETIT MAL EPILEPSY 10 0.0020
356 PARALYSIS 28 0.0020
357 NERVOUS SYSTEM DISORDER 61 0.0020
358 BLOOD CREATINE PHOSPHOKINASE INCREASED 56 0.0019
359 SCOLIOSIS 12 0.0019
360 APNOEA 15 0.0019
361 MUSCULOSKELETAL STIFFNESS 168 0.0019
362 PARADOXICAL DRUG REACTION 7 0.0019
363 INTENTIONAL SELF-INJURY 38 0.0019
364 LETHARGY 108 0.0019
365 RETINOPATHY 7 0.0019
366 BRADYKINESIA 11 0.0019
367 SLUGGISHNESS 19 0.0019
368 TEARFULNESS 8 0.0019
369 POOR QUALITY SLEEP 40 0.0019
370 AUTOIMMUNE THYROIDITIS 7 0.0018
371 BRADYPHRENIA 12 0.0018
372 MOOD ALTERED 50 0.0018
373 IMMOBILE 8 0.0018
374 SPINAL OSTEOARTHRITIS 16 0.0018
375 VISION BLURRED 250 0.0018
376 HYPERKERATOSIS 10 0.0018
377 CONCUSSION 14 0.0018
378 BLOOD SODIUM DECREASED 34 0.0018
379 HYPOGLYCAEMIA 87 0.0018
380 SKIN ODOUR ABNORMAL 7 0.0018
381 SENSORY LOSS 14 0.0017
382 CARDIAC MURMUR 15 0.0017
383 BACK DISORDER 28 0.0017
384 TOOTHACHE 31 0.0017
385 SNEEZING 38 0.0017
386 PHARYNGOLARYNGEAL PAIN 9 0.0017
387 MENTAL STATUS CHANGES 47 0.0017
388 SINUS TACHYCARDIA 24 0.0017
389 JOINT INJURY 36 0.0017
390 ATAXIA 20 0.0017
391 PULSE ABSENT 8 0.0017
392 CHOLELITHIASIS 55 0.0017
393 SLEEP TERROR 7 0.0017
394 APHAGIA 8 0.0017
395 HYPERTENSION 352 0.0017
396 OSTEOARTHRITIS 70 0.0016
397 BUNDLE BRANCH BLOCK LEFT 7 0.0016
398 DEPRESSED MOOD 87 0.0016
399 COLD SWEAT 29 0.0016
400 UTERINE LEIOMYOMA 12 0.0016
401 DRUG WITHDRAWAL SYNDROME 144 0.0016
402 HORMONE LEVEL ABNORMAL 8 0.0016
403 COMA 78 0.0016
404 VITAMIN D DECREASED 14 0.0016
405 NEUROPATHY PERIPHERAL 155 0.0016
406 ADVERSE DRUG REACTION 146 0.0016
407 CEREBRAL DISORDER 12 0.0016
408 THYROID DISORDER 25 0.0016
409 NERVE INJURY 18 0.0016
410 ATRIOVENTRICULAR BLOCK FIRST DEGREE 7 0.0016
411 GLAUCOMA 31 0.0016
412 ORAL PAIN 36 0.0016
413 WRONG TECHNIQUE IN DRUG USAGE PROCESS 58 0.0016
414 HEART RATE IRREGULAR 36 0.0016
415 ACCIDENT 19 0.0016
416 UNRESPONSIVE TO STIMULI 41 0.0016
417 CHOLECYSTITIS ACUTE 9 0.0016
418 PHYSICAL DISABILITY 7 0.0016
419 FIBROMYALGIA 38 0.0016
420 ARRHYTHMIA 74 0.0016
421 RENAL FAILURE CHRONIC 12 0.0016
422 SLEEP DISORDER 110 0.0016
423 URINARY RETENTION 52 0.0016
424 DRUG EXPOSURE DURING PREGNANCY 53 0.0016
425 EYE DISORDER 51 0.0015
426 CARDIOMEGALY 19 0.0015
427 NICOTINE DEPENDENCE 12 0.0015
428 COGNITIVE DISORDER 72 0.0015
429 CONFUSIONAL STATE 249 0.0015
430 DEMENTIA 43 0.0015
431 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 11 0.0015
432 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
433 DECREASED INTEREST 9 0.0015
434 GASTRITIS 40 0.0015
435 LIVER FUNCTION TEST ABNORMAL 44 0.0015
436 BLADDER DISORDER 15 0.0015
437 INSURANCE ISSUE 23 0.0015
438 NECK PAIN 84 0.0015
439 ORAL DISORDER 11 0.0015
440 BLINDNESS TRANSIENT 11 0.0015
441 HYPERHIDROSIS 192 0.0015
442 BREAST MASS 10 0.0015
443 ARTERIOSCLEROSIS 14 0.0015
444 GASTRIC DISORDER 51 0.0015
445 ANKLE FRACTURE 23 0.0015
446 DRUG EFFECT DECREASED 80 0.0015
447 DRUG LEVEL DECREASED 15 0.0015
448 SYNCOPE 147 0.0015
449 DRY MOUTH 118 0.0015
450 HEAD INJURY 46 0.0015
451 AUTISM SPECTRUM DISORDER 8 0.0015
452 DRUG INTERACTION 230 0.0014
453 DENTAL CARIES 16 0.0014
454 PHOTOPSIA 9 0.0014
455 BLOOD GLUCOSE INCREASED 268 0.0014
456 FEELING JITTERY 27 0.0014
457 EXPIRED DRUG ADMINISTERED 7 0.0014
458 HYPOTHYROIDISM 45 0.0014
459 ANHEDONIA 37 0.0014
460 AGRANULOCYTOSIS 26 0.0014
461 HYPOAESTHESIA ORAL 21 0.0014
462 BLOOD MAGNESIUM DECREASED 12 0.0014
463 FURUNCLE 11 0.0014
464 HEART RATE INCREASED 137 0.0014
465 SKIN LACERATION 15 0.0014
466 DRUG DISPENSING ERROR 21 0.0014
467 WEIGHT DECREASED 382 0.0014
468 POLLAKIURIA 57 0.0014
469 GASTROOESOPHAGEAL REFLUX DISEASE 110 0.0014
470 PNEUMONIA ASPIRATION 34 0.0014
471 PERIPHERAL VASCULAR DISORDER 7 0.0014
472 CHEST PAIN 251 0.0014
473 IRRITABLE BOWEL SYNDROME 29 0.0014
474 RESPIRATORY ARREST 37 0.0013
475 MALABSORPTION 7 0.0013
476 MEMORY IMPAIRMENT 184 0.0013
477 MULTIPLE FRACTURES 22 0.0013
478 THERAPEUTIC RESPONSE UNEXPECTED 60 0.0013
479 PARTIAL SEIZURES 7 0.0013
480 VENTRICULAR TACHYCARDIA 22 0.0013
481 PALPITATIONS 156 0.0013
482 SKIN DISORDER 44 0.0013
483 NYSTAGMUS 7 0.0013
484 FOOD POISONING 7 0.0013
485 RESPIRATION ABNORMAL 9 0.0013
486 STEVENS-JOHNSON SYNDROME 29 0.0013
487 CARDIAC DISORDER 122 0.0013
488 HAIR GROWTH ABNORMAL 9 0.0013
489 BLOOD POTASSIUM DECREASED 39 0.0013
490 APHASIA 39 0.0013
491 ELECTROLYTE IMBALANCE 15 0.0013
492 WOUND 36 0.0013
493 MIDDLE INSOMNIA 24 0.0013
494 JAW DISORDER 7 0.0013
495 TOOTH ABSCESS 13 0.0013
496 DRUG ADMINISTRATION ERROR 39 0.0013
497 HYSTERECTOMY 11 0.0013
498 FOOT FRACTURE 24 0.0013
499 HYPOAESTHESIA 189 0.0013
500 TEMPERATURE INTOLERANCE 13 0.0013
501 POLYNEUROPATHY 15 0.0013
502 DRUG INTOLERANCE 121 0.0013
503 ANGIOPATHY 7 0.0012
504 LEUKOPENIA 62 0.0012
505 RESPIRATORY RATE INCREASED 11 0.0012
506 DELIRIUM 43 0.0012
507 GASTROENTERITIS 18 0.0012
508 CHOKING 24 0.0012
509 SUBSTANCE ABUSE 10 0.0012
510 CHOLECYSTECTOMY 14 0.0012
511 BODY TEMPERATURE INCREASED 25 0.0012
512 NEUROLOGICAL SYMPTOM 7 0.0012
513 BODY TEMPERATURE DECREASED 12 0.0012
514 CARPAL TUNNEL SYNDROME 17 0.0012
515 DISABILITY 24 0.0012
516 DEPRESSED LEVEL OF CONSCIOUSNESS 48 0.0012
517 ANAPHYLACTIC REACTION 67 0.0012
518 COMPLETED SUICIDE 101 0.0012
519 MENSTRUAL DISORDER 10 0.0012
520 ARTERIOSCLEROSIS CORONARY ARTERY 8 0.0012
521 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 63 0.0012
522 MEDICATION ERROR 67 0.0012
523 DECREASED ACTIVITY 13 0.0012
524 OEDEMA 65 0.0012
525 HYPOVOLAEMIA 7 0.0012
526 HEART RATE DECREASED 42 0.0012
527 FEELING OF BODY TEMPERATURE CHANGE 7 0.0012
528 PAROSMIA 9 0.0012
529 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
530 HYPOTHERMIA 12 0.0012
531 TROPONIN INCREASED 9 0.0012
532 GENERAL PHYSICAL CONDITION ABNORMAL 8 0.0012
533 INCORRECT ROUTE OF DRUG ADMINISTRATION 42 0.0012
534 LIPASE INCREASED 9 0.0012
535 CARDIAC PACEMAKER INSERTION 7 0.0012
536 CHRONIC KIDNEY DISEASE 89 0.0012
537 INTESTINAL OBSTRUCTION 44 0.0012
538 LOW DENSITY LIPOPROTEIN INCREASED 9 0.0012
539 PRESYNCOPE 28 0.0012
540 UNEVALUABLE EVENT 86 0.0011
541 ULCER 18 0.0011
542 THERMAL BURN 8 0.0011
543 RETCHING 24 0.0011
544 WRONG DRUG ADMINISTERED 10 0.0011
545 SENSORY DISTURBANCE 18 0.0011
546 DIPLOPIA 29 0.0011
547 RHINITIS 9 0.0011
548 VISUAL ACUITY REDUCED 37 0.0011
549 MUSCLE SPASMS 204 0.0011
550 INTERVERTEBRAL DISC PROTRUSION 24 0.0011
551 BONE DISORDER 20 0.0011
552 ASPIRATION 12 0.0011
553 DRUG PRESCRIBING ERROR 21 0.0011
554 TACHYCARDIA 97 0.0011
555 CHOLECYSTITIS 13 0.0011
556 MIGRAINE 104 0.0011
557 GAIT DISTURBANCE 208 0.0011
558 RHINORRHOEA 70 0.0011
559 FOOT DEFORMITY 12 0.0011
560 DRY THROAT 11 0.0011
561 VISUAL IMPAIRMENT 134 0.0011
562 HIATUS HERNIA 14 0.0011
563 INJURY 76 0.0011
564 RHABDOMYOLYSIS 45 0.0011
565 THROAT TIGHTNESS 29 0.0011
566 OSTEOPOROSIS 44 0.0011
567 SENSATION OF FOREIGN BODY 9 0.0011
568 FLANK PAIN 10 0.0011
569 TINNITUS 49 0.0011
570 DYSURIA 39 0.0011
571 CARDIO-RESPIRATORY ARREST 44 0.0011
572 CHILLS 123 0.0010
573 CYST 13 0.0010
574 DIZZINESS 519 0.0010
575 JOINT DISLOCATION 11 0.0010
576 PHARMACEUTICAL PRODUCT COMPLAINT 27 0.0010
577 PARAESTHESIA 163 0.0010
578 ATELECTASIS 10 0.0010
579 TOOTH DISORDER 23 0.0010
580 DIZZINESS POSTURAL 10 0.0010
581 BLOOD GLUCOSE ABNORMAL 19 0.0010
582 BRONCHITIS 76 0.0010
583 VITAMIN D DEFICIENCY 10 0.0010
584 BLOOD TESTOSTERONE DECREASED 7 0.0010
585 MENORRHAGIA 20 0.0010
586 HEAD DISCOMFORT 18 0.0010
587 INTENTIONAL OVERDOSE 65 0.0010
588 FEELING HOT 62 0.0010
589 FACIAL PAIN 9 0.0010
590 ANAL INCONTINENCE 9 0.0010
591 CARDIAC ARREST 82 0.0010
592 DYSSTASIA 29 0.0010
593 OVERDOSE 213 0.0010
594 POST PROCEDURAL INFECTION 8 0.0010
595 MALNUTRITION 11 0.0010
596 BLISTER 55 0.0010
597 HAEMORRHOIDS 19 0.0010
598 QUALITY OF LIFE DECREASED 13 0.0010
599 PHARYNGITIS 12 0.0010
600 MYOCARDIAL ISCHAEMIA 11 0.0010
601 MICTURITION URGENCY 11 0.0010
602 VENTRICULAR EXTRASYSTOLES 10 0.0010
603 BALANCE DISORDER 83 0.0010
604 LACERATION 9 0.0010
605 CONTUSION 92 0.0010
606 UPPER LIMB FRACTURE 19 0.0010
607 CARDIOMYOPATHY 14 0.0009
608 BRADYCARDIA 50 0.0009
609 BREAST PAIN 10 0.0009
610 RESPIRATORY DISORDER 28 0.0009
611 END STAGE RENAL DISEASE 17 0.0009
612 HERNIA 18 0.0009
613 MUSCULOSKELETAL DISCOMFORT 16 0.0009
614 PHARYNGITIS STREPTOCOCCAL 10 0.0009
615 MYOCLONUS 11 0.0009
616 TRANSIENT ISCHAEMIC ATTACK 31 0.0009
617 RENAL FAILURE 122 0.0009
618 PULMONARY THROMBOSIS 10 0.0009
619 HEPATOMEGALY 9 0.0009
620 TOOTH INFECTION 12 0.0009
621 DEEP VEIN THROMBOSIS 59 0.0009
622 ANGINA PECTORIS 26 0.0009
623 FOOD ALLERGY 7 0.0009
624 INABILITY TO AFFORD MEDICATION 9 0.0009
625 ATRIOVENTRICULAR BLOCK 7 0.0009
626 PULMONARY EMBOLISM 86 0.0009
627 MUSCULOSKELETAL CHEST PAIN 14 0.0009
628 VENTRICULAR FIBRILLATION 10 0.0009
629 BLOOD UREA INCREASED 15 0.0009
630 CORONARY ARTERY DISEASE 27 0.0009
631 HYPOKALAEMIA 41 0.0009
632 CONDITION AGGRAVATED 270 0.0009
633 GASTROENTERITIS VIRAL 16 0.0009
634 POST PROCEDURAL COMPLICATION 17 0.0009
635 LEUKOCYTOSIS 16 0.0009
636 DRUG EFFECT INCOMPLETE 32 0.0009
637 RENAL DISORDER 41 0.0009
638 MUSCULOSKELETAL PAIN 46 0.0009
639 PERIPHERAL COLDNESS 12 0.0009
640 BLOOD DISORDER 7 0.0009
641 CELLULITIS 44 0.0009
642 UPPER RESPIRATORY TRACT INFECTION 40 0.0009
643 NEURALGIA 21 0.0009
644 OEDEMA PERIPHERAL 105 0.0009
645 WHITE BLOOD CELL COUNT INCREASED 33 0.0009
646 MALAISE 377 0.0009
647 OSTEOPENIA 13 0.0009
648 ILL-DEFINED DISORDER 52 0.0009
649 HYPERSENSITIVITY 158 0.0009
650 EMOTIONAL DISTRESS 103 0.0008
651 RASH GENERALISED 22 0.0008
652 RENAL PAIN 9 0.0008
653 GLOSSODYNIA 19 0.0008
654 DIALYSIS 12 0.0008
655 FALL 281 0.0008
656 RENAL INJURY 25 0.0008
657 VOMITING 392 0.0008
658 ACUTE RESPIRATORY FAILURE 16 0.0008
659 CONSTIPATION 181 0.0008
660 EAR INFECTION 22 0.0008
661 FEELING COLD 23 0.0008
662 PELVIC PAIN 15 0.0008
663 SEIZURE 95 0.0008
664 TOOTH LOSS 17 0.0008
665 COELIAC DISEASE 8 0.0008
666 THERAPY CHANGE 8 0.0008
667 BURNING SENSATION 57 0.0008
668 HYPOTONIA 8 0.0008
669 RENAL FAILURE ACUTE 34 0.0008
670 GRIP STRENGTH DECREASED 7 0.0008
671 HEADACHE 496 0.0008
672 GASTRIC ULCER 15 0.0008
673 GASTROINTESTINAL INFECTION 7 0.0008
674 LOWER LIMB FRACTURE 15 0.0008
675 LIMB DISCOMFORT 24 0.0008
676 LIMB INJURY 21 0.0008
677 FATIGUE 599 0.0008
678 PLATELET COUNT INCREASED 10 0.0008
679 NAUSEA 607 0.0008
680 HYPONATRAEMIA 43 0.0008
681 JOINT STIFFNESS 20 0.0008
682 BACK PAIN 177 0.0008
683 HYPERTHYROIDISM 11 0.0008
684 DYSPNOEA 430 0.0008
685 IMMUNE SYSTEM DISORDER 10 0.0008
686 MYALGIA 129 0.0008
687 NERVE COMPRESSION 7 0.0008
688 IRON DEFICIENCY ANAEMIA 7 0.0008
689 HYPOKINESIA 11 0.0008
690 ARTHROPATHY 42 0.0008
691 RESPIRATORY TRACT CONGESTION 12 0.0008
692 GLYCOSYLATED HAEMOGLOBIN INCREASED 19 0.0008
693 DEHYDRATION 100 0.0007
694 HAEMATEMESIS 19 0.0007
695 ALANINE AMINOTRANSFERASE INCREASED 46 0.0007
696 BODY HEIGHT DECREASED 8 0.0007
697 LOCAL SWELLING 13 0.0007
698 DRUG DOSE OMISSION 123 0.0007
699 ABDOMINAL PAIN UPPER 152 0.0007
700 BLINDNESS 30 0.0007
701 RED BLOOD CELL COUNT DECREASED 21 0.0007
702 IMPAIRED GASTRIC EMPTYING 10 0.0007
703 RIB FRACTURE 15 0.0007
704 CORONARY ARTERY OCCLUSION 10 0.0007
705 DRUG INEFFECTIVE 958 0.0007
706 TOOTH FRACTURE 8 0.0007
707 DYSPEPSIA 71 0.0007
708 VIRAL INFECTION 24 0.0007
709 DISCOMFORT 44 0.0007
710 BLOOD PRESSURE INCREASED 110 0.0007
711 HEPATIC ENZYME INCREASED 49 0.0007
712 KIDNEY INFECTION 14 0.0007
713 LIGAMENT SPRAIN 7 0.0007
714 BLOOD PRESSURE DECREASED 47 0.0007
715 MITRAL VALVE INCOMPETENCE 8 0.0007
716 PAIN IN JAW 20 0.0007
717 HAEMATOCRIT DECREASED 14 0.0007
718 ASTHENIA 265 0.0007
719 BLOOD PRESSURE ABNORMAL 14 0.0007
720 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 50 0.0007
721 RECTAL HAEMORRHAGE 30 0.0007
722 DRUG DEPENDENCE 112 0.0007
723 ASPARTATE AMINOTRANSFERASE INCREASED 37 0.0007
724 NEOPLASM 8 0.0007
725 EMPHYSEMA 7 0.0007
726 HEPATIC CIRRHOSIS 13 0.0007
727 CYSTITIS 22 0.0007
728 CAESAREAN SECTION 8 0.0007
729 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 33 0.0007
730 BLOOD URINE PRESENT 13 0.0007
731 MYOCARDIAL INFARCTION 119 0.0007
732 ABDOMINAL PAIN 158 0.0007
733 RASH 296 0.0007
734 ADVERSE REACTION 9 0.0007
735 NEPHROLITHIASIS 31 0.0007
736 BLOOD IRON DECREASED 8 0.0007
737 ADVERSE EVENT 62 0.0007
738 CATARACT 40 0.0007
739 WRIST FRACTURE 8 0.0007
740 BLOOD PRESSURE FLUCTUATION 16 0.0007
741 PRODUCT TASTE ABNORMAL 9 0.0007
742 INTERSTITIAL LUNG DISEASE 32 0.0007
743 NOCTURIA 8 0.0007
744 WHEEZING 39 0.0007
745 SKIN ULCER 17 0.0007
746 ABDOMINAL DISCOMFORT 110 0.0007
747 FACE OEDEMA 11 0.0007
748 RESPIRATORY DISTRESS 18 0.0007
749 ARTHRITIS 51 0.0006
750 ORAL DISCOMFORT 9 0.0006
751 NASAL CONGESTION 38 0.0006
752 TENDONITIS 10 0.0006
753 EYE SWELLING 24 0.0006
754 ILEUS 8 0.0006
755 BLOOD TEST ABNORMAL 9 0.0006
756 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
757 BLOOD GLUCOSE FLUCTUATION 7 0.0006
758 PAIN IN EXTREMITY 188 0.0006
759 MENSTRUATION IRREGULAR 17 0.0006
760 DYSGEUSIA 47 0.0006
761 MUSCLE ATROPHY 8 0.0006
762 SWELLING FACE 41 0.0006
763 SCIATICA 10 0.0006
764 ALOPECIA 123 0.0006
765 PULMONARY HYPERTENSION 13 0.0006
766 ROTATOR CUFF SYNDROME 8 0.0006
767 INFLUENZA LIKE ILLNESS 51 0.0006
768 FLATULENCE 35 0.0006
769 BLOOD POTASSIUM INCREASED 10 0.0006
770 DERMATITIS CONTACT 7 0.0006
771 DIVERTICULITIS 17 0.0006
772 MUSCULAR WEAKNESS 69 0.0006
773 VERTIGO 37 0.0006
774 DECREASED APPETITE 140 0.0006
775 ACCIDENTAL OVERDOSE 22 0.0006
776 SPINAL FRACTURE 12 0.0006
777 CHEST DISCOMFORT 61 0.0006
778 OROPHARYNGEAL PAIN 55 0.0006
779 ABDOMINAL PAIN LOWER 15 0.0006
780 URINARY TRACT INFECTION 101 0.0006
781 HEMIPARESIS 10 0.0006
782 PAIN 361 0.0006
783 GINGIVAL BLEEDING 8 0.0006
784 CARDIAC FAILURE CONGESTIVE 47 0.0006
785 CEREBROVASCULAR ACCIDENT 99 0.0006
786 GASTROINTESTINAL DISORDER 52 0.0006
787 BURSITIS 7 0.0006
788 DEAFNESS 15 0.0006
789 MASS 8 0.0006
790 CYANOSIS 9 0.0006
791 LIP SWELLING 19 0.0006
792 ENCEPHALOPATHY 14 0.0006
793 FUNGAL INFECTION 19 0.0006
794 MOUTH ULCERATION 12 0.0006
795 EYE PAIN 32 0.0006
796 GENERALISED OEDEMA 7 0.0006
797 ABSCESS 9 0.0006
798 LIVER DISORDER 25 0.0006
799 BLOOD ALKALINE PHOSPHATASE INCREASED 14 0.0006
800 LACRIMATION INCREASED 17 0.0006
801 BLOOD GLUCOSE DECREASED 27 0.0006
802 ASTHMA 63 0.0006
803 POISONING 7 0.0006
804 SINUSITIS 57 0.0006
805 PRODUCT SUBSTITUTION ISSUE 32 0.0006
806 BRAIN OEDEMA 7 0.0006
807 ALTERED STATE OF CONSCIOUSNESS 12 0.0006
808 HYPOPHAGIA 14 0.0005
809 HEPATITIS 14 0.0005
810 DYSPHONIA 32 0.0005
811 THERAPY CESSATION 28 0.0005
812 DRUG LEVEL INCREASED 9 0.0005
813 ANAPHYLACTIC SHOCK 14 0.0005
814 LABORATORY TEST ABNORMAL 16 0.0005
815 RESPIRATORY FAILURE 39 0.0005
816 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 38 0.0005
817 CIRCULATORY COLLAPSE 9 0.0005
818 PRODUCT AVAILABILITY ISSUE 12 0.0005
819 SWELLING 49 0.0005
820 AGEUSIA 13 0.0005
821 PALLOR 14 0.0005
822 INTENTIONAL PRODUCT MISUSE 45 0.0005
823 URTICARIA 86 0.0005
824 BLOOD PRESSURE SYSTOLIC INCREASED 10 0.0005
825 FLUID RETENTION 26 0.0005
826 BONE DENSITY DECREASED 16 0.0005
827 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 28 0.0005
828 PRURITUS GENERALISED 11 0.0005
829 PRODUCT USE COMPLAINT 8 0.0005
830 WHITE BLOOD CELL COUNT DECREASED 55 0.0005
831 JOINT SWELLING 61 0.0005
832 INCORRECT DOSE ADMINISTERED 112 0.0005
833 DIARRHOEA 316 0.0005
834 PHOTOSENSITIVITY REACTION 8 0.0005
835 PRODUCT USE IN UNAPPROVED INDICATION 118 0.0005
836 SKIN LESION 13 0.0005
837 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 16 0.0005
838 HYPOTENSION 95 0.0005
839 CARDIOVASCULAR DISORDER 12 0.0005
840 SCAR 8 0.0005
841 HOT FLUSH 35 0.0005
842 HEPATIC FAILURE 14 0.0005
843 FAECES DISCOLOURED 10 0.0005
844 SURGERY 27 0.0005
845 PYREXIA 159 0.0005
846 ACUTE KIDNEY INJURY 70 0.0005
847 HYPOXIA 16 0.0005
848 LYMPHADENOPATHY 16 0.0005
849 LIVER INJURY 11 0.0004
850 FEEDING DISORDER 9 0.0004
851 PNEUMOTHORAX 7 0.0004
852 RHEUMATOID ARTHRITIS 50 0.0004
853 HAEMATURIA 15 0.0004
854 ACNE 33 0.0004
855 SKIN DISCOLOURATION 20 0.0004
856 NIGHT SWEATS 14 0.0004
857 BLOOD CREATININE INCREASED 28 0.0004
858 PRURITUS 164 0.0004
859 INCORRECT DRUG ADMINISTRATION DURATION 12 0.0004
860 PNEUMONIA 138 0.0004
861 ANAEMIA 81 0.0004
862 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
863 FRACTURE 8 0.0004
864 DEPENDENCE 23 0.0004
865 COUGH 117 0.0004
866 NEUTROPHIL COUNT DECREASED 17 0.0004
867 PERICARDITIS 7 0.0004
868 HOSPITALISATION 64 0.0004
869 GENERAL PHYSICAL HEALTH DETERIORATION 48 0.0004
870 THROMBOSIS 33 0.0004
871 BONE PAIN 24 0.0004
872 ARTHRALGIA 170 0.0004
873 JAUNDICE 11 0.0004
874 ATRIAL FIBRILLATION 39 0.0004
875 PREGNANCY 8 0.0004
876 PRODUCT QUALITY ISSUE 54 0.0004
877 NASOPHARYNGITIS 73 0.0004
878 PRODUCT ADMINISTRATION ERROR 8 0.0004
879 DRUG ERUPTION 7 0.0004
880 HAEMOPTYSIS 11 0.0004
881 STAPHYLOCOCCAL INFECTION 13 0.0004
882 EPILEPSY 12 0.0004
883 VAGINAL HAEMORRHAGE 17 0.0004
884 SHOCK 9 0.0004
885 GOUT 7 0.0004
886 DRY SKIN 52 0.0004
887 LUNG DISORDER 19 0.0004
888 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
889 PRODUCT USE ISSUE 72 0.0004
890 KNEE ARTHROPLASTY 8 0.0004
891 PULMONARY OEDEMA 17 0.0004
892 DISEASE RECURRENCE 18 0.0004
893 INTENTIONAL PRODUCT USE ISSUE 33 0.0004
894 MULTIPLE SCLEROSIS 18 0.0004
895 MOBILITY DECREASED 27 0.0004
896 BACTERIAL INFECTION 7 0.0004
897 OFF LABEL USE 328 0.0004
898 ABORTION SPONTANEOUS 15 0.0004
899 OXYGEN SATURATION DECREASED 21 0.0004
900 HYPOACUSIS 16 0.0004
901 INFLAMMATION 19 0.0004
902 MUSCULOSKELETAL DISORDER 7 0.0004
903 ERYTHEMA 75 0.0004
904 THERAPEUTIC RESPONSE DECREASED 22 0.0004
905 EXPIRED PRODUCT ADMINISTERED 12 0.0004
906 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
907 ORAL HERPES 7 0.0004
908 C-REACTIVE PROTEIN INCREASED 13 0.0004
909 RASH PAPULAR 8 0.0004
910 PERICARDIAL EFFUSION 8 0.0003
911 ABDOMINAL DISTENSION 36 0.0003
912 FLUSHING 35 0.0003
913 RASH ERYTHEMATOUS 16 0.0003
914 HAEMATOCHEZIA 18 0.0003
915 PRODUCT DISPENSING ERROR 7 0.0003
916 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
917 INFECTION 46 0.0003
918 RASH MACULO-PAPULAR 7 0.0003
919 TOXICITY TO VARIOUS AGENTS 53 0.0003
920 INFLUENZA 35 0.0003
921 HYPERKALAEMIA 11 0.0003
922 DRUG RESISTANCE 8 0.0003
923 HAEMATOMA 8 0.0003
924 ACUTE MYOCARDIAL INFARCTION 9 0.0003
925 PLATELET COUNT DECREASED 32 0.0003
926 BREAST CANCER FEMALE 8 0.0003
927 BLOOD BILIRUBIN INCREASED 8 0.0003
928 THROAT IRRITATION 13 0.0003
929 TREATMENT FAILURE 24 0.0003
930 LOCALISED INFECTION 7 0.0003
931 PROCEDURAL PAIN 8 0.0003
932 EPISTAXIS 21 0.0003
933 STOMATITIS 17 0.0003
934 HIP FRACTURE 9 0.0003
935 RASH PRURITIC 15 0.0003
936 DRUG ABUSE 23 0.0003
937 PRODUCT DOSE OMISSION 18 0.0003
938 HAEMORRHAGE 28 0.0003
939 THERAPY NON-RESPONDER 12 0.0003
940 SKIN BURNING SENSATION 19 0.0003
941 COLITIS 10 0.0003
942 DRY EYE 13 0.0003
943 RASH MACULAR 9 0.0003
944 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
945 PRODUCT ADHESION ISSUE 9 0.0003
946 PRODUCTIVE COUGH 12 0.0003
947 METABOLIC ACIDOSIS 8 0.0002
948 ILLNESS 25 0.0002
949 PERIPHERAL SWELLING 37 0.0002
950 SKIN EXFOLIATION 20 0.0002
951 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 48 0.0002
952 MATERNAL EXPOSURE DURING PREGNANCY 21 0.0002
953 UNDERDOSE 17 0.0002
954 FEMUR FRACTURE 7 0.0002
955 NEOPLASM MALIGNANT 15 0.0002
956 CARDIAC FAILURE 18 0.0002
957 GAIT INABILITY 7 0.0002
958 EYE PRURITUS 7 0.0002
959 SEPSIS 23 0.0002
960 DEATH 177 0.0002
961 MULTIPLE SCLEROSIS RELAPSE 14 0.0002
962 ANGIOEDEMA 9 0.0002
963 DEVICE BREAKAGE 8 0.0002
964 HERPES ZOSTER 11 0.0002
965 PSORIASIS 25 0.0002
966 RENAL IMPAIRMENT 16 0.0002
967 HEPATIC FUNCTION ABNORMAL 7 0.0002
968 HAEMOGLOBIN DECREASED 19 0.0002
969 BREAST CANCER 17 0.0002
970 NO ADVERSE EVENT 33 0.0002
971 PLEURAL EFFUSION 11 0.0002
972 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
973 EYE IRRITATION 10 0.0002
974 EXTRA DOSE ADMINISTERED 7 0.0002
975 GASTROINTESTINAL HAEMORRHAGE 14 0.0002
976 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 28 0.0002
977 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
978 ECZEMA 8 0.0002
979 THROMBOCYTOPENIA 17 0.0002
980 OCULAR HYPERAEMIA 7 0.0001
981 PRODUCT DOSE OMISSION ISSUE 42 0.0001
982 INJECTION SITE BRUISING 11 0.0001
983 INJECTION SITE PAIN 40 0.0001
984 EXPOSURE DURING PREGNANCY 8 0.0001
985 COVID-19 22 0.0001
986 NEUTROPENIA 16 0.0001
987 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
988 INJECTION SITE PRURITUS 7 0.0001
989 INJECTION SITE REACTION 7 0.0001
990 DISEASE PROGRESSION 10 0.0001
991 INJECTION SITE ERYTHEMA 7 0.0001